chrX-74421899-A-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006517.5(SLC16A2):ā€‹c.262A>Gā€‹(p.Thr88Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000215 in 1,209,178 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000035 ( 0 hom., 1 hem., cov: 24)
Exomes š‘“: 0.000020 ( 0 hom. 8 hem. )

Consequence

SLC16A2
NM_006517.5 missense

Scores

1
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.727
Variant links:
Genes affected
SLC16A2 (HGNC:10923): (solute carrier family 16 member 2) This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04390073).
BP6
Variant X-74421899-A-G is Benign according to our data. Variant chrX-74421899-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 412284.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}.
BS2
High Hemizygotes in GnomAdExome4 at 8 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC16A2NM_006517.5 linkuse as main transcriptc.262A>G p.Thr88Ala missense_variant 1/6 ENST00000587091.6 NP_006508.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC16A2ENST00000587091.6 linkuse as main transcriptc.262A>G p.Thr88Ala missense_variant 1/61 NM_006517.5 ENSP00000465734 P1
SLC16A2ENST00000636771.1 linkuse as main transcriptc.10A>G p.Thr4Ala missense_variant, NMD_transcript_variant 1/75 ENSP00000490445

Frequencies

GnomAD3 genomes
AF:
0.0000355
AC:
4
AN:
112767
Hom.:
0
Cov.:
24
AF XY:
0.0000286
AC XY:
1
AN XY:
34927
show subpopulations
Gnomad AFR
AF:
0.0000964
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000575
AC:
1
AN:
174038
Hom.:
0
AF XY:
0.0000159
AC XY:
1
AN XY:
62944
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000131
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000201
AC:
22
AN:
1096411
Hom.:
0
Cov.:
32
AF XY:
0.0000221
AC XY:
8
AN XY:
362229
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000261
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000355
AC:
4
AN:
112767
Hom.:
0
Cov.:
24
AF XY:
0.0000286
AC XY:
1
AN XY:
34927
show subpopulations
Gnomad4 AFR
AF:
0.0000964
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000868
Hom.:
1
Bravo
AF:
0.0000151
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 21, 2023The c.484A>G (p.T162A) alteration is located in exon 1 (coding exon 1) of the SLC16A2 gene. This alteration results from a A to G substitution at nucleotide position 484, causing the threonine (T) at amino acid position 162 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Spastic paraplegia Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpSep 01, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-1.1
CADD
Benign
15
DANN
Benign
0.74
DEOGEN2
Benign
0.15
T
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.36
T
M_CAP
Benign
0.0064
T
MetaRNN
Benign
0.044
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.1
L
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.56
T
Sift4G
Benign
0.76
T
Polyphen
0.0010
B
Vest4
0.075
MutPred
0.22
Loss of glycosylation at T88 (P = 0.0044);
MVP
0.068
MPC
0.86
ClinPred
0.0072
T
GERP RS
1.6
Varity_R
0.053
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs751226641; hg19: chrX-73641734; API